Current Opinion in Lipidology volume 24, issue 6, P493-499 2013 DOI: 10.1097/mol.0000000000000022 View full text
Barbara V. Howard, Jacques E. Rossouw

Abstract: Purpose of Review In 2002 and 2004, the Women’s Health Initiative (WHI) found no evidence that hormone therapy (HT) with estrogen or estrogen with progestin (E+P) protected against cardiovascular disease (CVD). Since then, further analyses have been performed. This review summarizes current analyses on the effects of HT on CVD and CVD risk factors. Recent Findings The negative effects of HT vary by type of CVD event. Estrogen alone and E+P show consistent effects on CVD, but E+P has more impact on coronary…

expand abstract